Steven T. Harris MD F.A.C.P.
Diabetes, Lipid Metabolism
Clinical Professor of Medicine, UCSF
Join to View Full Profile
1635 Divisadero St.Suite 525San Francisco, CA 94115
Phone+1 415-682-0914
Fax+1 415-451-2167
Dr. Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Harris is an endocrinologist in San Francisco, CA and is affiliated with UCSF Medical Center. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 43 years. He specializes in osteoporosis, metabolic bone disease and disorders of mineral metabolism.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1983
Beth Israel Deaconess Medical CenterFellowship, Internal Medicine, 1979 - 1981
University of California (San Francisco)Residency, Internal Medicine, 1975 - 1978- University of California (San Francisco)Internship, Internal Medicine, 1974 - 1975
- University of California San Francisco School of MedicineClass of 1974
Certifications & Licensure
MA State Medical License 1979 - Present
CA State Medical License 1975 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Best Doctors in America
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- 24 citationsHistory of etidronateNelson B. Watts, Charles H. Chesnut, Harry K. Genant, Steven T. Harris, Rebecca D. Jackson
Bone. 2020-05-01 - 10 citationsWestern Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for Osteoporosis.E. Michael Lewiecki, David L. Kendler, K. Shawn Davison, David A. Hanley, Steven T. Harris
The American Journal of Medicine. 2019-05-29 - 15 citationsProceedings of the 2017 Santa Fe Bone Symposium: Insights and Emerging Concepts in the Management of OsteoporosisE. Michael Lewiecki, John P. Bilezikian, John J. Carey, Richard M. Dell, Catherine M. Gordon
Journal of Clinical Densitometry. 2018-01-01
Journal Articles
- Understanding and communicating the benefits and risks of denosumab, raloxifene, and teriparatide for the treatment of osteoporosisEM Lewiecki, PD Miller, ST Harris, DC Bauer, KS Davison, L Dian, DA Hanley, MR McClung, CK Yuen, DL Kendler, J Clin Densitom.;17(4):490-5. doi: 10.1016/j.jocd.2013.09.018. Epub 2013 Oct 25, 2014
- Longterm fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studiesPD Miller, RR Recker, S Harris, S Silverman, D Felsenberg, J Reginster, BM Day, C Barr, D Masanauskaite, Osteoporos.Int.;25(1):349-57, 2014
- Bone mineral density in patients with alopecia areata treated with long-term intralesional corticosteroidsA Samrao, JM Fu, ST Harris, VH Price, J.Drugs Dermatol.;12(2):e36-40, 2013
Professional Memberships
- Member
- Member
- Member
- National Osteoporosis FoundationMember
- American Society for Bone and Mineral ResearchMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
